The thrombophilic network of autoantibodies in celiac disease

Aaron Lerner1, Nancy Agmon-Levin, Yinon Shapira

  • 1Pediatric Gastroenterology and Nutrition Unit, Carmel Medical Center, B, Rappaport School of Medicine, Technion-Israel institute of Technology, Michal St, No 7, Haifa, 34362, Israel. lerner_aaron@clalit.org.il

BMC Medicine
|April 6, 2013
PubMed

Insights

Celiac disease patients show higher levels of antiphosphatidylserine/prothrombin and antiprothrombin antibodies, suggesting these may contribute to thrombophilia. This finding could inform new anticoagulant therapies for celiac disease.

Area of Science:

  • Immunology
  • Gastroenterology
  • Hematology

Background:

  • Celiac disease is an autoimmune disorder linked to genetic susceptibility and thromboembolic events.
  • Thrombophilia in celiac disease involves factors like hyperhomocysteinemia and vitamin deficiencies.
  • Antiphosphatidylserine/prothrombin and antiprothrombin antibodies have not been previously studied in celiac disease.

Purpose of the Study:

  • To investigate the presence and levels of antiphosphatidylserine/prothrombin and antiprothrombin antibodies in individuals with celiac disease.
  • To compare autoantibody levels in celiac disease patients with healthy children and their family members.

Main Methods:

  • Serum autoantibody levels were measured using enzyme-linked immunosorbent assay (ELISA) in 248 participants.
  • Participants were divided into three groups: children with celiac disease (n=70), healthy children (n=88), and adult family members (n=90).

Main Results:

  • Individuals with celiac disease exhibited significantly higher levels of antiphosphatidylserine/prothrombin IgG antibodies compared to controls (P <0.0001).
  • Elevated antiprothrombin immunoglobulin G levels were observed in celiac disease patients and their family members compared to healthy children (P <0.005).
  • A higher percentage of celiac disease patients were positive for antiphosphatidylserine/prothrombin antibodies (45.7%) versus controls (0%).

Conclusions:

  • Increased autoantibodies, including antiphosphatidylserine/prothrombin and antiprothrombin, are associated with celiac disease.
  • These autoantibodies may play a role in the thrombophilia observed in celiac disease.
  • The identified autoantibodies could serve as potential markers for developing preventive anticoagulant therapies.
Abstract

Related Concept Videos

Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...